Al Barsha gas explosion: Woman battles for life after suffering severe burns
A Dubai resident continues to battle for her life after sustaining severe burn injuries in a gas explosion in her building in Al Barsha earlier this month. Annalyn, who was staying on the first floor of the building directly above the restaurant where the gas explosion occurred, sustained 65 per cent burn injuries and is in the burn unit of a government hospital, according to her sister Angely.
'Ever since I got the call about her, I have been worried sick,' Angely told Khaleej Times over phone. 'I work in Saudi Arabia as a nurse, and I have not yet been able to travel to the UAE. I am hoping to come there by the end of May when I will be able to get a few days of leave.'
On May 13, a fire had broken out at the Al Zarooni building on Halim Street in Barsha 1.
According to Dubai Civil Defense (DCD), the incident was caused by a gas leak in a restaurant and was contained in record time. Several residents reported that they had spent the following days with friends and family.
According to Angely, her sister and her brother-in-law suffered burn injuries and were rushed to the hospital. Her sister was in a more critical condition and remains in the burn unit while her brother-in-law is more stable and is recovering in the ward. 'It was quite late in the night, and they were preparing to go to bed,' she said. 'That is when the disaster occurred.'
Timely updates
She said the hospital staff had been giving her family timely updates about Annelyn's condition but there was a long road to recovery. In photos seen by Khaleej Times, the Filipina can be seen on a hospital bed surrounded by medical equipment. The sister confirmed that Annalyn has been tracheostomized- a process where an opening is surgically created through the neck into the windpipe to allow air to fill the lungs.
'We are worried about their hospital bills and how their future life is going to be,' she said. 'Recovering from burn injuries can take a very long time and requires constant care and attention.'
One of the main breadwinners of the family, Annalyn and her husband have been UAE residents for over a decade. Although she started off her career as a receptionist, Annalyn had recently moved jobs to work at a gym where her husband had been a long-time employee.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
30 minutes ago
- Zawya
M42, AstraZeneca, and SOPHiA GENETICS launch UAE broad liquid biopsy initiative to transform cancer diagnosis and care
Partnership will advance cancer diagnosis, inform treatment decisions, and enable real-time monitoring of disease progression in a more cost-effective and less invasive manner The launch is expected in the latter part of Q2 2025, following the completion of an initial validation study at Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates: M42, a global health leader powered by technology, continues to pioneer artificial intelligence (AI) and medical and clinical solutions as part of its mission to revolutionize health in the UAE and globally. In a major advancement for precision oncology, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS (Nasdaq: SOPH) to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of cancers. As part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood draw. This approach does not replace but rather complements routine cancer screenings and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer profile. Over the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the UAE. The new testing program will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the region. Validation studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 2025. Over time, the collaboration will serve as a foundation for broader expansion across the Middle East, excluding Saudi Arabia, delivering world-class precision oncology solutions to a wider population. Albarah El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said: "At M42, we are committed to transforming care through innovation and collaboration. By partnering with AstraZeneca and SOPHiA GENETICS, we are bringing world-class liquid biopsy technologies to the UAE, empowering clinicians to deliver more precise and less invasive cancer care. This collaboration reflects our vision of democratizing health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalized care." Sameh El Fangary, Cluster President GCC, AstraZeneca, shared," At AstraZeneca, we are leading the way in the application of precision medicine. Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimizing patient pathways from detection to therapy.' R oss Muken, President of SOPHiA GENETICS, said: "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalize care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." About M42 M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
Khaleej Times
an hour ago
- Khaleej Times
Liv Hospital City Walk achieves landmark JCI 8th Edition accreditation
Liv Hospital City Walk, the first Middle East venture of one of Turkey's largest private healthcare networks, MLPCare, has marked a major milestone in its early journey by securing accreditation under the Joint Commission International's (JCI) newly released 8th Edition standards. The achievement places the Dubai-based hospital among the first in the region to be recognised under these elevated global criteria for patient safety, clinical governance, and health service continuity. Located in the heart of City Walk, Liv Hospital officially opened its doors in late 2024. It has since grown into a 24/7 facility staffed by over 60 physicians and nearly 200 healthcare professionals, providing multidisciplinary care across a range of medical specialties. Backed by over 25 years of medical expertise in Turkey and Europe, the hospital integrates academic rigor with advanced clinical services to serve a rapidly growing patient population in the UAE. The JCI 8th Edition standards, introduced to reflect modern healthcare challenges, place increased emphasis on digital health, sustainability, risk management, and integrated patient-centric care. Liv Hospital City Walk's accreditation under this framework underscores its commitment to continuous improvement and high standards in service delivery. 'Achieving accreditation under JCI's 8th Edition is more than recognition — it is a reflection of our deeply rooted culture of clinical quality and operational integrity,' said Dr Özgun Güngör, general surgery specialist and general manager of Liv Hospital City Walk. 'This milestone represents a collective commitment to excellence by our medical and administrative teams. As Liv Hospital's representative in the UAE, I am proud of the progress we've made in such a short time.' Liv Hospital City Walk is the latest development in MLPCare's growing international footprint, which spans over 38 hospitals across Turkey, the UK, Hungary, Kosovo, and Azerbaijan. The expansion into Dubai reflects the group's long-term vision of delivering high-quality, ethical, and technologically advanced healthcare to global communities. Developed in close academic collaboration with Istinye University, the hospital benefits from a robust academic ecosystem. Graduates from the university's faculties of medicine, dentistry, and nursing now contribute to the hospital's clinical depth, helping foster a practice that is grounded in evidence-based medicine and innovation. Liv Hospital City Walk offers advanced care in key medical areas such as interventional cardiology, neuro and spine surgery, general surgery, gastroenterology, dental services, and aesthetic medicine. The hospital's patient-centered model emphasises collaborative diagnosis and treatment planning, with safety and transparency at its core. In a short span, the facility has emerged as a regional center of excellence—attracting both local and international patients seeking high standards of personalised care and medical expertise. Part of the MLPCare international healthcare network, Liv Hospital City Walk is located in Dubai's City Walk district and delivers comprehensive, round-the-clock medical services. The hospital combines clinical excellence, modern infrastructure, and academic collaboration to set new standards in ethical and evidence-based healthcare across the region.
The National
an hour ago
- The National
UAE sends 3,000 food packages to Sudanese refugees in Chad
Aid will support 15,000 refugees, says Ministry of Foreign Affairs The UAE has sent 3,000 packages of food aid to refugees in Chad who have been displaced by Sudan's civil war. The aid will support 15,000 Sudanese refugees across three main camps. Dougui camp received 1,500 food packages, benefiting 7,500 people; Alacha camp received 1,300 packages for 6,500 people; and Abougoudam received 200 packages for 1,000 people, the Ministry of Foreign Affairs said. The project aims to meet essential needs for a month, while improving food security and living conditions. 'This endeavour is part of the UAE's humanitarian and development approach, which places the welfare and dignity of individuals at the forefront,' said Rashid Al Shamsi, UAE Ambassador to Chad. 'Furthermore, the project underscores the UAE's steadfast commitment to supporting those affected by crises and conflicts, particularly in regions experiencing mass displacement and severe humanitarian challenges. 'This important undertaking reflects the UAE's sustained and extensive efforts to bolster the socio-economic well-being of host communities in Chad.' Essential aid supplies would ensure decent livelihoods, address regional displacement challenges and support vulnerable populations globally, added the ambassador. 'Our aim is to enhance the humanitarian and living conditions of refugees through direct assistance and international co-operation,' he said. The Sudanese Armed Forces are wrestling with the paramilitary Rapid Support Forces and allies for control of the country. Almost 13 million people, one in three Sudanese, have been displaced since the conflict began in April 2023.
